Immune Globul G/Gly/Iga Avg 46
Brand name: Gamunex-C
Rank #70 of 500 drugs by total cost
$266.5M
Total Cost
27,501
Total Claims
$266.5M
Total Cost
950
Prescribers
$9,692
Cost per Claim
293
Beneficiaries
27,930
30-Day Fills
$281K
Avg Cost/Provider
29
Avg Claims/Provider
About Immune Globul G/Gly/Iga Avg 46
Immune Globul G/Gly/Iga Avg 46 (sold as Gamunex-C) was prescribed 27,501 times by 950 Medicare Part D providers in 2023, costing the program $266.5M. At $9,692 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 67 | Selexipag (Uptravi) | $279.1M | 12,320 |
| 68 | Liraglutide (Victoza 3-Pak) | $273.0M | 189,358 |
| 69 | Elexacaftor/Tezacaftor/Ivacaft (Trikafta) | $269.3M | 9,821 |
| 70 | Immune Globul G/Gly/Iga Avg 46 (Gamunex-C) | $266.5M | 27,501 |
| 71 | Rosuvastatin Calcium (Rosuvastatin Calcium) | $264.9M | 11,259,701 |
| 72 | Risankizumab-Rzaa (Skyrizi Pen) | $259.7M | 12,539 |
| 73 | Venetoclax (Venclexta) | $259.6M | 28,191 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology